Institutional Learning Curve of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Malignancies

[1] Sugarbaker PH(2006)New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 7 69-76

[2] McBride K(2013)Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis J Surg Res. 183 246-252

[3] McFadden D(2012)Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms Ann Surg Oncol. 19 1386-1393

[4] Osler T(2008)Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center Ann Surg Oncol. 15 754-763

[5] Austin F(2012)Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer Clin Colorectal Cancer. 11 167-176

[6] Mavanur A(2010)Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis Cancer. 116 3756-3762

[7] Sathaiah M(2006)Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy Ann Surg Oncol. 13 635-644

[8] Gusani NJ(2006)Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique Cancer. 106 1144-1153

[9] Cho SW(2009)Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy J Surg Oncol. 100 293-296

[10] Colovos C(2007)Learning curve of combined modality treatment in peritoneal surface disease Br J Surg. 94 1408-1414

[1] Sugarbaker PH(2006)New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 7 69-76

[2] McBride K(2013)Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis J Surg Res. 183 246-252

[3] McFadden D(2012)Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms Ann Surg Oncol. 19 1386-1393

[4] Osler T(2008)Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center Ann Surg Oncol. 15 754-763

[5] Austin F(2012)Current status of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer Clin Colorectal Cancer. 11 167-176

[6] Mavanur A(2010)Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis Cancer. 116 3756-3762

[7] Sathaiah M(2006)Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy Ann Surg Oncol. 13 635-644

[8] Gusani NJ(2006)Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique Cancer. 106 1144-1153

[9] Cho SW(2009)Learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy J Surg Oncol. 100 293-296

[10] Colovos C(2007)Learning curve of combined modality treatment in peritoneal surface disease Br J Surg. 94 1408-1414